Miriam Tenorio

Miriam Tenorio

26 Jun, 2025

“I reached out to Celegence with an urgent project that we could not complete internally. Celegence immediately established a team of experts to strategize next steps. They started project execution nearly overnight and worked seamlessly with our internal team. I would strongly recommend Celegence and their team of experts to anyone facing resource challenges or regulatory hurdles.”

Other Related Articles

MDR Article 117: What It Means — And How We Help You Get Ahead

Blog Medical Devices

MDR Article 117: What It Means — And How We Help You Get Ahead

16 Apr, 2026

Heavy Metals in Pharmaceuticals: A Critical Quality and Safety Imperative

Blog Pharmaceutical

Heavy Metals in Pharmaceuticals: A Critical Quality and Safety Imperative

10 Apr, 2026

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era

Blog Pharmaceutical

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era

01 Apr, 2026

Expanded Access Approval : Balancing Urgency and Oversight in Regulatory Affairs

Blog Pharmaceutical

Expanded Access Approval : Balancing Urgency and Oversight in Regulatory Affairs

26 Mar, 2026

How to Reduce Notified Body Review Cycles Through Better Clinical Documentation

Blog Medical Devices

How to Reduce Notified Body Review Cycles Through Better Clinical Documentation

18 Mar, 2026

The Great Convergence — Why 2026 is the Year Regulatory “Records” Die

Blog Pharmaceutical

The Great Convergence — Why 2026 is the Year Regulatory “Records” Die

10 Mar, 2026

Raw Material Compliance in Pharmaceuticals: Naming, Pharmacopeial Grade, and Safety Requirements

Blog Pharmaceutical

Raw Material Compliance in Pharmaceuticals: Naming, Pharmacopeial Grade, and Safety Requirements

24 Feb, 2026

EMA Upgrades xEVMPD Web Interface

Blog Pharmaceutical

EMA Upgrades xEVMPD Web Interface

19 Feb, 2026

View All